Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors
Status:
Not yet recruiting
Trial end date:
2022-12-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether stereotactic body radiotherapy (SBRT)
combined with recombined human granulocyte-macrophage colony stimulating factor(rhGM-CSF) and
Peginterferon alfa-2b is safe, effective in the treatment of patients with metastatic thymic
epithelial tumors.